HOME >> BIOLOGY >> NEWS
Umbilical cord blood transplants, bone marrow transplants save lives

MAYWOOD, Ill. Umbilical cord blood and bone marrow transplants at Loyola University are curing or slowing the progression of many cancers originating in the bone marrow (i.e., leukemia, myeloma) or lymphatic system (lymphoma).

More than 106,000 people in the U.S. each year are diagnosed with these life-threatening diseases.

"Even if other treatments have produced no results, a bone marrow transplant may save the patient's life," said Dr. Patrick J. Stiff, director of the Cardinal Bernardin Cancer Center and the Bone Marrow Transplant Program at Loyola University Medical Center, Maywood, Ill. Patients unable to find a matching bone marrow donor may have an alternative with umbilical cord blood (CB) transplantation.

Loyola's unique method of preparing the umbilical cord blood enables more stem cells to survive, according to Stiff, who also is professor of Medicine and Pathology, Loyola University Chicago Stritch School of Medicine.

A transplant provides the patient with healthy, new stem cells to develop a new immune system. And it's working.

Holly Drucker, 30, of Chicago's north side; Adam McGillen, 25, of Sandwich, Ill.; Moira Minielly, 39, of Wilmette, Ill.; and Donna Marasco, 45, of Bolingbrook, Ill., were dying of cancer when they arrived at Loyola's Cardinal Bernadin Cancer Center during the past six years. At Loyola, Holly and Adam underwent umbilical cord blood transplant for non-Hodgkin's lymphoma. Moira, diagnosed with non-Hodgkin's lymphoma, and Donna, with chronic myelogenous leukemia, underwent bone marrow transplant at Loyola. Today all four are leading productive, happy lives.

Loyola has the largest bone marrow transplantation program in the Midwest, performing 160 transplants each year. It is a participating center in the National Marrow Donor Program network.

The latest statistics from the National Marrow Donor Program Network show the actual one-year patient su
'"/>

Contact: Joanne Swanson
jswanson@lumc.edu
708-216-2445
Loyola University Health System
1-Jun-2004


Page: 1 2 3

Related biology news :

1. Umbilical cord matrix, a rich new stem cell source, study shows
2. Duke Study Shows Umbilical Cord Blood Transplant Is Viable Treatment For Genetic Disorders
3. Experimental drug shown to block mutant protein causing blood disease
4. IBD (Crohns, Colitis) joins cancer, inflammatory diseases in associated blood vessel growth
5. A probable cause for high blood pressure identified - shows links with diabetes
6. Probing the surface of white blood cells to enhance immune system medicine
7. Streptococcus infects humans by thwarting blood clotting
8. Strep disrupts blood clotting to infect humans
9. Nucleic acid-amplification testing further safeguards nations blood supply
10. Hopkins scientists use blood proteins to detect ovarian cancer
11. Marijuana ingredient inhibits VEGF pathway required for brain tumor blood vessels

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/6/2020)... (PRWEB) , ... February 06, 2020 , ... ... to facilitate access to unique lab-made bioresearch materials, today announced an agreement with ... and plant-based meat and seafood a reality. Under the partnership, terrestrial meat and ...
(Date:1/29/2020)... ... January 29, 2020 , ... Jason Burke has joined CREO, ... providing consulting services for strategy, research and development and data governance to healthcare ... Managing Partner of CREO, an innovative management consulting and advisory firm based in ...
(Date:1/27/2020)... ... January 27, 2020 , ... On Thursday, February 20, 2020 at 10am ... Reed Tech and Richard Castle, Global Account Manager Medical Device at PRISYM ... topics include EU MDR timing deadlines, best practices in creating and submitting product data ...
Breaking Biology News(10 mins):
(Date:2/3/2020)... ... February 03, 2020 , ... ... Cambridge, MA, announce that OmniType, the 11-locus, single tube multiplex successor to Holotype ... a best-in-class product featuring locus-multiplexing and short library preparation, for HLA genotyping from ...
(Date:1/27/2020)... ... January 27, 2020 , ... Valencell, the leading ... strategic investors led by Halma plc , a FTSE 100 global group ... GII LLC, and WSJ Joshua Fund. A representative from Halma will join the ...
(Date:1/22/2020)... (PRWEB) , ... January 20, 2020 , ... ... announced a partnership with WAVE Electronics, the largest independent electronics distributor in the ... to purchase Brilliant Smart Home Systems with leading smart home products from a ...
(Date:1/10/2020)... ... January 09, 2020 , ... ... today announced the acquisition of Cunesoft, a move that expands the company’s portfolio ... of life sciences companies. , Based in Munich, Germany, Cunesoft provides intelligent software ...
Breaking Biology Technology:
Cached News: